New Results
Recall of pre-existing cross-reactive B cell memory following Omicron breakthrough infection
View ORCID ProfileChengzi I. Kaku, Alan J. Bergeron, View ORCID ProfileClas Ahlm, Johan Normark, View ORCID ProfileMrunal Sakharkar, View ORCID ProfileMattias N. E. Forsell, View ORCID ProfileLaura M. Walker
doi: https://doi.org/10.1101/2022.04.01.486726
Chengzi I. Kaku
1Adimab, LLC, Lebanon, NH 03766, USA
Alan J. Bergeron
2Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH 03766, USA
3Department of Microbiology and Immunology, Dartmouth College, Hanover, NH 03755, USA
Clas Ahlm
4Division of Immunology, Department of Clinical Microbiology, Umea University, Umea, Sweden
Johan Normark
4Division of Immunology, Department of Clinical Microbiology, Umea University, Umea, Sweden
Mrunal Sakharkar
1Adimab, LLC, Lebanon, NH 03766, USA
Mattias N. E. Forsell
4Division of Immunology, Department of Clinical Microbiology, Umea University, Umea, Sweden
Laura M. Walker
1Adimab, LLC, Lebanon, NH 03766, USA
5Adagio Therapeutics, Inc., Waltham, MA 02451, USA
Posted April 01, 2022.
Recall of pre-existing cross-reactive B cell memory following Omicron breakthrough infection
Chengzi I. Kaku, Alan J. Bergeron, Clas Ahlm, Johan Normark, Mrunal Sakharkar, Mattias N. E. Forsell, Laura M. Walker
bioRxiv 2022.04.01.486726; doi: https://doi.org/10.1101/2022.04.01.486726
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14972)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28085)
- Molecular Biology (11592)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7340)
- Zoology (1651)